Search for: "SLATE MARKETING, INC." Results 21 - 40 of 352
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Sep 2023, 6:27 am
Securities and Exchange Commission, on Thursday, September 28, 2023 Tags: Climate Risk Disclosure, Crypto, equity markets, SEC [read post]
29 Sep 2023, 6:27 am
Securities and Exchange Commission, on Thursday, September 28, 2023 Tags: Climate Risk Disclosure, Crypto, equity markets, SEC [read post]
23 Aug 2011, 7:11 am by Sheldon Toplitt
Journal editorial attacking him, writing a column for Slate.com entitled "They Still Don't Get It," defending his prosecutorial pursuit of Marsh & McClennan and American Insurance Group Inc. [read post]
13 Apr 2007, 7:59 am by Micah
Smolla, Dean and Professor of Law, Washington & Lee University School of Law; Micah Buchdahl, President of HTMLawyers, Inc.; Susan Kay, Associate Dean for Clinical Affairs and Clinical Professor of Law, Vanderbilt University Law School. [read post]
30 Jun 2023, 6:30 am
Commentary: Our Proxy Advice is Apolitical Posted by Subodh Mishra, Institutional Shareholder Services, Inc., on Friday, June 23, 2023 Tags: ESG, Institutional Investors, Monetary policy, Proxy advisors, Proxy voting, Shareholder activism Nine Mistakes To Avoid When Transitioning CEOs Posted by Joseph M. [read post]
30 Jun 2023, 6:30 am
Commentary: Our Proxy Advice is Apolitical Posted by Subodh Mishra, Institutional Shareholder Services, Inc., on Friday, June 23, 2023 Tags: ESG, Institutional Investors, Monetary policy, Proxy advisors, Proxy voting, Shareholder activism Nine Mistakes To Avoid When Transitioning CEOs Posted by Joseph M. [read post]
15 Aug 2014, 11:43 am by Eric Goldman
In addition to the movie’s references to Clean Slate, there were fictional websites referencing Clean Slate that supported the movie’s marketing. [read post]
31 Oct 2012, 10:31 am by Jenna Greene
He also represented Watson Pharmaceuticals Inc. in its $5.9 billion purchase of Swiss drug maker Actavis Inc., which was approved by the FTC (with divestitures) earlier in October. [read post]
5 Dec 2011, 6:16 am by Andrew Ramonas
Securities and Exchange Commission and Citigroup Global Markets Inc. last week, Jenna Greene explores whether companies would settle with federal agencies if forced to admit wrongdoing. [read post]
5 Mar 2021, 6:03 am
Underwriters Do Not Use Green Shoe Options to Profit from IPO Stock Pops Posted by Robert Evans, Locke Lord LLP, on Friday, February 26, 2021 Tags: Capital formation, Capital markets, Equity offerings, IPOs, Market reaction, Regulation M, Securities regulation, Underwriting New Tactics and ESG Themes Change the Direction of Shareholder Activism Posted by Richard J. [read post]
25 Feb 2016, 7:32 am by Allred & Allred
The tablets made by the company, Qualitest Pharmaceuticals Inc., reportedly contained less than half of the fluoride claimed. [read post]
25 Feb 2016, 7:32 am by Allred & Allred
The tablets made by the company, Qualitest Pharmaceuticals Inc., reportedly contained less than half of the fluoride claimed. [read post]
25 Feb 2016, 7:32 am by Allred & Allred
The tablets made by the company, Qualitest Pharmaceuticals Inc., reportedly contained less than half of the fluoride claimed. [read post]
25 Feb 2016, 7:32 am by Allred & Allred
The tablets made by the company, Qualitest Pharmaceuticals Inc., reportedly contained less than half of the fluoride claimed. [read post]
7 Nov 2007, 4:19 am
[…] See also Facebook aims to match ads to users — pdf; also Facebook Is Marketing Your Brand Preferences (With Your Permission); also Slate’s Is Facebook the Next Google? [read post]
Although the two most influential proxy advisory firms, Institutional Shareholder Services Inc. and Glass Lewis & Co., both supported Trian’s slate of director nominees, DuPont’s three largest institutional shareholders, The Vanguard Group, Blackrock, Inc. and State Street Corporation, all voted in favor of DuPont’s slate. [read post]
25 Jul 2022, 5:00 am by John Jascob
As an example, he noted the SEC’s charges against BNY Mellon Investment Adviser, Inc. for misstatements and omissions about ESG considerations in certain mutual funds it managed. [read post]